#1

Portfolio, M&A, and Commercial Strategy

Kardam supports portfolio and product‑selection strategy in pharmaceuticals, aligning API capabilities, CGMP capacity, and commercial priorities. The firm also provides business‑case development and diligence support for mergers and acquisitions, including asset and platform evaluations, and assists with business development and licensing, carve‑outs, and integration of generic and API assets into existing pharmaceutical manufacturing platforms.

#2 Operational Turnarounds and Efficiency

The firm advises on operational turnarounds where performance, compliance, and service levels are critical to value. Engagements include multi‑year efficiency programs, yield and cost‑of‑goods improvements, and stabilizing CGMP manufacturing and supply chain performance under sponsor or corporate ownership.

#3 API and Drug Product Manufacturing

Kardam helps evaluate and design API and finished‑dose manufacturing networks across international, multi‑site operations. Work typically addresses network rationalization, site carve‑outs, CGMP readiness, and capital allocation to improve manufacturing efficiency and resilience in generic and branded drugs and APIs.

#4 Investor and Board Advisory

Kardam serves private equity firms, lenders, and boards seeking an independent operating view on pharmaceutical, API, and CDMO/CMO platforms. Typical mandates include investment and investment‑committee (IC) support, board‑level operating reviews, leadership and organization design at the CEO/COO/CCO level, and ongoing advisory roles for sponsors and strategic acquirers.

#5 Sectors and Focus Areas

Pharmaceuticals, including oral solid, sterile, special delivery systems, and high‑potency products
Active pharmaceutical ingredients, excipients, and intermediates
Pharmaceutical supply chain and CGMP manufacturing networks
CEO, COO, and CCO‑level leadership transitions and operating model design in complex organizations

R&D Product Selection and Portfolio Optimization

Optimize Your R&D and Portfolio Strategy

In the pharmaceutical industry, aligning R&D efforts with market needs is critical for success. At Kardam Consulting, we provide strategic guidance to help companies optimize their R&D product selection and portfolio strategy, ensuring long-term growth and profitability.

Our Services

We offer a range of services designed to support R&D and portfolio optimization, including:

R&D Product Selection Programs: Identifying high-potential products that align with market needs and strategic goals.
Product & Portfolio Optimization: Streamlining portfolios to maximize value and minimize risk.
Pharmaceutical Portfolio Strategy: Developing strategies to align API capabilities, CGMP capacity, and commercial priorities.

Why Kardam Consulting?

Our team has extensive experience in pharmaceutical R&D and portfolio management, with a deep understanding of the challenges and opportunities in this space. We provide tailored solutions that deliver tangible results.

Case Study:

A pharmaceutical company sought guidance on optimizing its product portfolio. Kardam Consulting conducted a thorough analysis of their R&D pipeline, identifying high-potential products and streamlining their portfolio. The result was a more focused and profitable product lineup.

Let’s Work Together

Looking to optimize your R&D and portfolio strategy? Kardam Consulting is your trusted partner.

Optimize your R&D and portfolio strategy—contact us to learn more.